Arbovirus testing market
Report ID: SQMIG35A3986
Report ID: SQMIG35A3986
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3986 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
186
|Figures:
79
Global Arbovirus Testing Market size was valued at USD 1.12 Billion in 2024 and is poised to grow from USD 1.17 Billion in 2025 to USD 1.66 Billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).
Surge in prevalence of arboviral diseases, increasing investments in disease surveillance programs, rising adoption of molecular diagnostic technologies, expanding public-private partnerships, and advancements in multiplex testing platforms are driving sales of arbovirus testing.
Growing implementation of multiplex PCR assays and automated diagnostic instruments and systems is streamlining testing processes and facilitating concurrent identification of diversified arboviruses using a single sample. Growing private sector-public sector relationships to enhance infrastructure of laboratories and early warning systems around the world are also assisting in market development. Incremental developments in card-based molecular test systems, automated sample processing modules and cloud-based surveillance systems are also furthering the potential use of testing. Furthermore, boosting government efforts to augment capacity of laboratories and strengthen infectious disease surveillance systems are expected to boost the prospectus of the market across the globe. High incidence of dengue, Zika, chikungunya, and other mosquito-borne viral infections, coupled with increasing investments in disease surveillance and outbreak preparedness, is expected to primarily drive arbovirus testing market growth.
On the contrary, high costs of advanced molecular diagnostic systems, limited laboratory infrastructure in low-resource regions, cross-reactivity in serological tests, and shortage of skilled laboratory professionals are predicted to slow down arbovirus testing market penetration over the coming years.
How is AI Improving Rapid Arbovirus Testing Accuracy And Turnaround Times?
Artificial Intelligence (AI) is revolutionizing the arboviruses testing market by enhancing the speed, accuracy, and efficiency of diagnostic testing procedures. Machine learning algorithms, embedded within ELISA readers and RT-PCR systems, analyze fluorescent signals and testing patterns instantaneously to facilitate more precise infection detection while minimizing manual analysis. Artificial intelligence also reduces background noise in lab tests, highlights result that are hard to interpret for further review, and new auto ruling capabilities increase confidence in diagnostic results. The use of connected lab systems allows laboratory physicians to transmit results and compile reports at a rapid pace during arbovirus outbreaks, speedily aiding in patient treatment decisions. AI enables multiplex testing systems that identify numerous arboviruses in a single test, maximizing lab operational efficiency and providing optimal patient treatment.
Market snapshot - (2026-2033)
Global Market Size
USD 1.12 Billion
Largest Segment
Molecular Tests (PCR/RT-PCR)
Fastest Growth
Multiplex Arbovirus Panels
Growth Rate
4.5% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global arbovirus testing market is segmented by test type, disease type, technology, end user, application, product type, and region. Based on test type, the market is segmented into molecular tests (PCR/RT-PCR), serological tests, antigen detection tests, neutralization assays, multiplex arbovirus panels, and rapid diagnostic tests (RDTs). Based on disease type, the market is segmented into dengue virus testing, zika virus testing, chikungunya virus testing, west nile virus testing, yellow fever virus testing, japanese encephalitis virus testing, and other arboviral diseases. Based on technology, the market is segmented into RT-PCR, ELISA, immunofluorescence assays, chemiluminescence immunoassays, next-generation sequencing, and point-of-care testing. Based on end user, the market is segmented into hospitals, diagnostic laboratories, public health laboratories, research institutes, and blood banks. Based on application, the market is segmented into clinical diagnostics, disease surveillance, outbreak investigation, blood screening, and research applications. Based on product type, the market is segmented into reagents & kits, instruments, testing services, and quality control materials. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The molecular tests segment is predicted to lead the global arbovirus testing market revenue generation across the study period. They give the greatest analytical sensitivity and specificity, which means they can detect viral RNA early in the course of acute infection. The ability to distinguish between mixed and closely related arboviruses helps in management of the individual patient, as well as guiding public health interventions. Laboratories favor them because they have been very well validated; they can be automated and therefore applied in existing molecular biology pipelines. They are recommended by regulatory authorities as reference methods, and the cost of reagents is reducing.
Meanwhile, rapid diagnostic tests segment emerges as the most rapidly expanding segment as per this arbovirus testing market forecast, as point of care formats deliver on site results, facilitating outbreak management and community-based screening. Ease of use, reduction in overall instrumentation and the increasing number of tested markers are all factors that health workers and decision makers are considering and therefore hastening uptake into the marketplace.
The diagnostic laboratories segment is slated to account for the highest global arbovirus testing market share in the future. They are the main sites for high throughput arbovirus testing-combining state of the art instrumentation with automation and special expertise. Their large test menus-covering multiple arboviruses-adds to their central position in providing both surveillance and patient management. Investment in laboratory information systems and quality accreditation strengthens their position and ensures re-direction of test requests from clinicians and public health agencies. Their participation in networked research projects and training of laboratory staff ensures a methodological consistency, improves laboratory methodology, and provides the opportunity for innovation.
Conversely, blood banks segment is witnessing the strongest growth momentum as increasing need for secure transfusions propels on-going screening of arboviruses, particularly within the endemic region. Gaining favor are new multiplex testing systems and fully automated serology instruments to improve the process and focus on pathogen reduction regulations intensify the acceptance of these technologies, making blood banks a primary growth sector.
To get detailed segments analysis, Request a Free Sample Report
Sophisticated laboratory networks, strong public-private collaboration, and substantial investment in infectious-disease research are helping support steady arbovirus testing demand in the region. North America has a well-established regulatory system that facilitates the speedy approval of new diagnostic platforms while adhering to high-quality assurance standards. Health care systems have developed strong early detection networks and comprehensive surveillance to encourage the widespread use of complex molecular and serological laboratory tests for diagnosing arboviruses. A highly skilled scientific workforce continues to promote innovation; and well-developed supply chains provide rapid distribution of diagnostic kits throughout multiple clinical settings. Collectively, these factors contribute to the development of a robust ecosystem that supports North America as the leader of the arbovirus diagnostic market and establishes it as a model for best practice approaches to arbovirus diagnostics.
Arbovirus testing market in the United States is characterized by extensive academic‑hospital networks that foster rapid translation of research into clinical practice. Robust funding mechanisms support the development of multiplex platforms, while large reference laboratories provide centralized testing capacity. Collaborative initiatives between government agencies and private firms enhance assay standardization and facilitate swift response to emerging threats. The market also benefits from a culture of continuous professional development among laboratory personnel, ensuring high competency in emerging diagnostic technologies.
Arbovirus testing market in Canada is driven by a coordinated national health strategy that prioritizes early detection and integrated disease monitoring. Strong ties between provincial health authorities and research institutions promote the adoption of cutting‑edge testing methods. Public health-based perspective spurs forward looking, adaptable laboratory infrastructure with capacity for differential expanded activity in public health outbreaks. Positive market influences include a focus on affordable technologies pushing at the edges of high throughput for quality delivery to hard to reach remote and urban populations.
Unified approach to health security, supported by collaborative research initiatives across borders are helping shape arbovirus testing demand across Europe. Furthermore, Europe has unified and harmonized its regulatory pathways to expedite the market launch of new innovations in diagnostic testing while maintaining comparable performance standards. Comprehensive surveillance is paramount to public health agencies, and thus advanced testing becomes part of the standard clinical workflow. In addition, the presence of strong academic clusters allows for continued enhancement of assay sensitivity as well as specificity and large amounts of funding directed to pathogen-focused programmes to increase the number of products in the pipeline. Furthermore, the growing awareness of the risk of vector-borne diseases continues to be a major factor in increasing demand for multiplex solutions, further solidifying Europe's position as a leading, active center for the ongoing improvement of arbovirus testing.
Arbovirus testing market in Germany benefits from a dense network of university hospitals that serve as centers of excellence for diagnostic innovation. Synergistic public private partnerships facilitate rapid transition of new assay technologies into clinical care. Stringent quality assurance allows high reproducibility of result, and strong export orientation pushes adherence to global norms. The market also benefits from evolved health informatics systems that integrate laboratory testing data to formulate a comprehensive picture of epidemiology.
Arbovirus testing market in the United Kingdom is propelled by proactive public health policies that embed diagnostic capacity within national disease surveillance programs. Key collaborative efforts include leading research institutions partnering with diagnostic companies to co-develop rapid point-of-care platforms. A focus on real-time data sharing improves response to outbreaks and directs resources. The sector is helped by a strong network of clinical trials that test new assays in different patient groups, improving preparedness.
Arbovirus testing market in France is emerging through strategic investments in regional diagnostic hubs that link university laboratories with public health laboratories. Collaborative frameworks support implementation of multiplex testing strategies adapted to local epidemiology, with value assigned to integrated disease management. Significant focus on multi-disciplinary research led to advances in the calibration and validation protocols. The benefits of launching multiplex testing into the market include an evolution of data collected in regionally oriented health registries.
Expanding diagnostic capacity and fostering innovation within rapidly growing healthcare systems are supporting steady demand for arbovirus testing in the region. Countries in the Asia-Pacific region are investing heavily to enhance the infrastructures of laboratories and create automation systems that increase productivity and reduce the time it takes to provide test results. Through collaboration, countries within the Asia-Pacific region are developing a greater level of quality and expertise around developing and sharing assay development expertise that is well-matched to the unique climate and vectors present in the Asia-Pacific region. Local and national governments are focusing on improving their disease surveillance capabilities, using arboviral testing as part of their overall public health strategies. Increasingly, biotechnology companies participate in the arboviral diagnostic sector as global suppliers of goods and services for developing local solutions for the region's specific demands, making the Asia-Pacific region an emerging market for advanced arboviral diagnostics.
Arbovirus testing market in Japan is distinguished by a strong emphasis on precision engineering and high‑quality manufacturing of diagnostic reagents. Close ties between research universities and industry accelerate the development of highly sensitive molecular assays. National health guidelines promote routine testing in both urban and rural settings, ensuring widespread accessibility. Integration of testing data with sophisticated health informatics platforms supports real‑time monitoring and informs public health decision‑making.
Arbovirus testing market in South Korea benefits from a vibrant biotech sector that rapidly prototypes innovative diagnostic kits. Government‑backed programs focus on enhancing laboratory automation and expanding networked testing sites across the country. Collaborative efforts between hospitals and research institutes drive optimization of assay performance for local virus strains. The market also leverages advanced data analytics to integrate testing results into comprehensive disease surveillance frameworks.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Awareness Of Arboviral Threats
Expansion Of Molecular Diagnostic Platforms
Limited Access To Advanced Laboratories
Regulatory Hurdles In Test Validation
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the global arbovirus testing market is shaped by intense rivalry among established diagnostic firms and emerging biotech players, driving rapid innovation and strategic collaborations. Companies are pursuing mergers and acquisitions to broaden assay portfolios, while partnerships with public health agencies accelerate the deployment of multiplex testing platforms. Notable examples include large diagnostics groups acquiring niche viral assay developers and forming joint ventures with regional laboratories to enhance surveillance capabilities.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, growing investments in disease surveillance programs, and rising adoption of molecular diagnostic technologies are anticipated to drive the demand for arbovirus testing going forward. However, high costs of advanced molecular diagnostic systems and limited laboratory infrastructure in low-resource regions are slated to slow down the adoption of arbovirus testing in the future. North America is slated to spearhead the demand for arbovirus testing owing to advanced diagnostic infrastructure, strong public health surveillance programs, and high investments in infectious disease research. AI-powered diagnostic platforms and expansion of multiplex molecular testing are anticipated to be key trends driving the arbovirus testing sector in the long run.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.12 Billion |
| Market size value in 2033 | USD 1.66 Billion |
| Growth Rate | 4.5% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Arbovirus testing market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Arbovirus testing market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Arbovirus testing market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Arbovirus testing market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Arbovirus Testing Market size was valued at USD 1.12 Billion in 2024 and is poised to grow from USD 1.17 Billion in 2025 to USD 1.66 Billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).
The competitive landscape of the global arbovirus testing market is shaped by intense rivalry among established diagnostic firms and emerging biotech players, driving rapid innovation and strategic collaborations. Companies are pursuing mergers and acquisitions to broaden assay portfolios, while partnerships with public health agencies accelerate the deployment of multiplex testing platforms. Notable examples include large diagnostics groups acquiring niche viral assay developers and forming joint ventures with regional laboratories to enhance surveillance capabilities. 'Roche Diagnostics', 'Abbott Laboratories', 'Danaher Corporation', 'Bio-Rad Laboratories', 'Thermo Fisher Scientific', 'QIAGEN', 'bioMérieux', 'Siemens Healthineers', 'Hologic', 'Seegene', 'SD Biosensor', 'OraSure Technologies', 'Trinity Biotech', 'CTK Biotech', 'InBios International', 'Arkray', 'Bioneer Corporation', 'GenBody', 'NovaTec Immundiagnostica', 'CerTest Biotec'
The growing public and professional awareness of arboviral disease transmission patterns drives demand for timely and accurate diagnostic services, encouraging health systems to allocate resources toward testing infrastructure. As communities recognize the health and economic impacts of outbreaks, policymakers prioritize preventive strategies that include widespread screening. This heightened consciousness creates a supportive environment for manufacturers to introduce innovative assay solutions, thereby expanding market reach and fostering sustained growth across both established and emerging regions through collaborative partnerships with local health agencies.
Expanded Point‑Of‑Care Platforms: Rapid adoption of portable, cartridge‑based testing devices is reshaping arbovirus detection by enabling clinicians to obtain results within minutes at clinic doors, airports, and field sites. These point‑of‑care platforms combine multiplex capabilities with minimal sample preparation, reducing reliance on centralized labs. As manufacturers streamline workflows and health systems prioritize early case identification, providers increasingly integrate these tools into routine triage, community screening, and outbreak containment strategies, driving broader market penetration and fostering greater resilience against seasonal and emergent vector‑borne threats.
Why does North America Dominate the Global Arbovirus testing market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
